Parkinson's Flashcards

1
Q

What is the definition of Parkinson’s disease

A

A progressive neurodegenerative disorder affecting dopaminergic neurones in the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the main triad of symptoms in Parkinson’s

A

Pill rolling tremor, rigidity and bradykinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What substance has been shown to cause severe Parkinsonism

A

MPTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a pathological hallmark of Parkinson’s

A

Lewy bodies in the substantia nigra - composed of alpha-synuclein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the frequency of the resting tremor

A

4-6 Hz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the central side effects of levodopa

A

Abnormal involuntary movements (dyskinesias)
Confusion
Visual hallucinations (patients are aware that these are hallucinations unlike psychosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the systemic side effects of levodopa

A

Nausea and vomiting
Anorexia
Postural hypotension
Fluctuating response (on/off syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the causes of Parkinsonism

A

Neurodegenerative disorders - idiopathic Parkinson’s disease, Parkinson’s plus syndromes
Drug induced: Antipsychotics, lithium, metoclopramide
Arteriosclerosis: atherosclerotic pseudoparkinsonism (legs only, less tremor)
Toxins: CO poisoning, MPTP
Congenital: Wilson’s disease
Trauma: Dementia pugilistica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you treat drug-induced Parkinsonism

A

Add anti-muscarinic - procyclidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What pathways are affected by Parkinson’s

A

Extrapyramidal pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What percentage of nigrostriatal dopaminergic neurones have to be lost for symptoms to appear

A

60-80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Would you expect to see the signs of Parkinson’s bilaterally

A

The physical signs are asymmetrical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the sensation of a patient like in Parkinson’s

A

It is normal and unaffected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the power of a patient in Parkinson’s

A

It is normal and unaffected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the reflexes of a patient like in Parkinson’s

A

Normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which direction are the plantar responses in Parkinson’s

A

Downgoing

17
Q

On examining the eyes of a Parkinson’s patient, what would you expect to find

A

Mild impairment of upgaze
Eyelids may be tremulous
Glabellar tap sign is elicited on repeated tapping (a primitive reflex)

18
Q

What features of multiple system atrophy differentiate it from Parkinson’s

A

Autonomic failure
Cerebellar dysfunction
Pyramidal features

In combination with extrapyramidal features

19
Q

On eye examination, how would you differentiate Parkinson’s from progressive supranuclear palsy

A

Failure of downgaze in progressive supranuclear palsy

Failure of voluntary gaze in progressive supranuclear palsy begins with loss of downgaze, then upgaze, then horizontal gaze

It is also associated with extrapyramidal dysfunction and dementia

20
Q

How can you partially alleviate side effects of levodopa (on/off syndrome and dyskinesias)

A

Frequent small doses of medications
Controlled release preparations
Combine levodopa use with - MAO-B inhibitor, COMT inhibitor or direct dopamine agonist to reduce central breakdown of dopamine

21
Q

Name a MAO-B inhibitor used in Parkinson’s

A

Selegiline

22
Q

Name a COMT inhibitor used in Parkinson’s

A

Entacapone

23
Q

Name some dopamine agonists used in Parkinson’s

A

Bromocriptine
Cabergoline

These drugs can also be used in early disease, potentially delaying the need for L-DOPA

Reduced use now due to side effects (valvular fibrosis defects)- non-ergolide versions preferred e.g. ropinerole

24
Q

What are the treatments used in PD?

A

Dopaminergic drugs: L-dopa: Motor symptoms
Dopamine agonists
MAO-B inhibitors

Anticholinergics: Reduce tremor
COMT inhibitors: Reduces GI breakdown of L-dopa
Glutamate antagonists: Amantadine
Apomorphine: reduce off periods

25
Q

What are the Parkinsons-plus syndromes?

A

Multi-system atrophy: Autonomic and cerebellar

Progressive supranuclear palsy: Eye movements

Corticobasilar degeneration: Unilateral parkinsonism with aphasia

Lewy Body Dementia: Visual hallucinations, fluctuating cognition

26
Q

What disability scale is used to assess disability in PD?

A

UPDRS- Unified Parkinson’s Disease Rating Scale

27
Q

How common are sleeping disorders in patients with Parkinson’s?

A

Affects around 90%.
Symptoms include: inability to turn, restless legs, insomnia, frequent waking.
Violent enactment of dreams (muscle atonia in REM sleep)

28
Q

What symptoms of autonomic dysfunction might patients complain of?

A
Postural hypotension
Constipation
Hypersalivation and dribbling
Urgency, frequency, nocturia
ED
Hyperhidrosis
29
Q

What mnemonic can be used to remember the side effects of L-DOPA?

A
DOPAMINE:
Dyskinesia
On-off phenomena
Psychosis
ABP decrease (autonomic postural hypotension?)
Mouth dryness
Insomnia
N/V
Excessive daytime sleepiness
30
Q

What is Parkinsonism?

A

A movement disorder characterised by bradykinesia and at least one of rest tremor, rigidity and postural instability

31
Q

How common is dementia in PD?

A

15-30% of patients, usually in late disease.

Earlier cognitive symptoms are suggestive of LBD

32
Q

What signs are suggestive of a Parkinsons-Plus syndrome?

A

Additional clinical features: pyramidal, cerebellar or ocular signs. Cognitive signs, early falls or postural instability.
Poor response to levodopa.
Symmetrical signs early in disease (PD is asymmetrical)

33
Q

How do you diagnose PD?

A

Clinical diagnosis
Imaging- exclude other pathologies.CT/MRI to exclude vascular cause.
Dopamine transported SPECT scan (uses 18-fluorodopa): loss of nigrostriatal dopamine transporter binding, cant distinguish PD and PSPs.

34
Q

What are the surgical options for PD management?

A

Eligible patients require a firm PD diagnosis and have responded well to dopaminergic therapy, be cognitively intact and predominantly motor-related disability:

Thalmotomy/subthalmotomy/pallidotomy: Destruction of parts of the brain overactive in PD.

Deep brain stimulation: Reversible.

Transplantation of dopamine producing cells: Currently in trials worldwide, ethical issues.